The Impact of CDH13 Polymorphism and Statin Administration on TG/HDL Ratio in Cardiovascular Patients

키워드

참고문헌 (33)

1. Orlik B, "Plasma omentin and adiponectin levels as markers of adipose tissue dysfunction in normal weight and obese women with polycystic ovary syndrome", Clin Endocrinol (Oxf), 81, pp.529~535 (2014)
2. Nakamura Y, "Relation of Serum Leptin and Adiponectin Level to Serum CReactive Protein: The INTERLIPID Study", Int J Vasc Med, 2013, pp.601364~ (2013)
3. Morisaki H, "CDH13 gene coding T-cadherin influences variations in plasma adiponectin levels in the Japanese population", Hum Mutat, 33, pp.402~410 (2012)
4. Kasahara DI, "Role of the adiponectin binding protein, T-cadherin (cdh13), in pulmonary responses to subacute ozone", PLoS One, 8, pp.e65829~ (2013)
5. Uetani E, "CDH13 genotype-dependent association of high-molecular weight adiponectin with all-cause mortality: the J-SHIPP study", Diabetes Care, 37, pp.396~401 (2014)
6. Mavroconstanti T, "Functional properties of rare missense variants of human CDH13found in adult attention deficit", hyperactivity disorder (ADHD) patients, 2013, pp.8, e71445~
7. Fredette BJ, "Inhibition of motor axon growth by T-cadherin substrata", Development, 122, pp.3163~3171 (1996)
8. Rubina K, "T-cadherin suppresses angiogenesis in vivo by inhibiting migration of endothelial cells", Angiogenesis, 10, pp.183~195 (2007)
9. Kyriakakis E, "T-cadherin attenuates the PERK branch of the unfolded protein response and protects vascular endothelial cells from endoplasmic reticulum stress-induced apoptosis", Cell Signal, 22, pp.1308~1316 (2010)
10. Philippova M, "Identification of proteins associating with glycosylphosphatidylinositol-anchored T-cadherin on the surface of vascular endothelial cells: role for Grp78", BiP in T-cadherin-dependent cell survival, 2008, pp.28, 4004~4017
11. Chung CM, "A genome-wide association study reveals a quantitative trait locus of adiponectin on CDH13 that predicts cardiometabolic outcomes", Diabetes, 60, pp.2417~2423 (2011)
12. He GX, "High-dose atorvastatin pretreatment could diminishes microvascular impairment in patients undergoing elective percutaneous coronary intervention", J Geriatr Cardiol, 10, pp.355~360 (2013)
13. Nusca A, "Statin loading before percutaneous coronary intervention: proposed mechanisms and applications", Future Cardiol, 6, pp.579~589 (2010)
14. Chung SD, "Statin use and clinical outcomes among pneumonia patients", Clin Microbiol Infect, 20, pp.879~885 (2014)
15. Vrablík M, "Impact of variants within seven candidate genes on statin treatment efficacy", Physiol Res, 61, pp.609~617 (2012)
16. Lee M, "Relationship between HDL3 subclasses and waist circumferences on the prevalence of metabolic syndrome: KMSRI-Seoul Study", Atherosclerosis, 213, pp.288~293 (2010)
17. Sull JW, "Serum adiponectin is associated with family history of diabetes independently of obesity and insulin resistance in healthy Korean men and women", Eur J Endocrinol, 160, pp.39~43 (2009)
18. Jee SH, "Adiponectin concentrations: a genome-wide association study", Am J Hum Genet, 87, pp.545~552 (2010)
19. Hug C, "T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30", adiponectin, 2004, pp.101, 10308~10313
20. Su TC, "Ageand gender-associated determinants of carotid intima-media thickness: a community-based study", J Atheroscler Thromb, 19, pp.872~880 (2012)
21. Org E, "Genome-wide scan identifies CDH13 as a novel susceptibility locus contributing to blood pressure determination in two European populations", Hum Mol Genet, 18, pp.2288~2296 (2009)
22. 이지현, "Association between CDH13 Variants and Cardiometabolic and Vascular Phenotypes in a Korean Population", Yonsei Medical Journal, 54(6), pp.1305~1312 (2013), 연세대학교의과대학[DOI]
23. Gao H, "Genetic variation in CDH13 is associated with lower plasma adiponectin levels but greater adiponectin sensitivity in East Asian populations", Diabetes, 62, pp.4277~4283 (2013)
24. Matsubara M, "Decreased plasma adiponectin concentrations in women with dyslipidemia", J Clin Endocrinol Metab, 87, pp.2764~2769 (2002)
25. Song B, "Association between statin use and short-term outcome based on severity of ischemic stroke: a cohort study", PLoS One, 9, pp.e84389~ (2014)
26. Zhou Q, "Simvastatin pharmacokinetics in healthy Chinese subjects and its relations with CYP2C9, CYP3A5, ABCB1, ABCG2 and SLCO1B1 polymorphisms", Pharmazie, 68, pp.124~128 (2013)
27. Lobo SM, "TNF-α modulates statin effects on secretion and expression of MCP-1, PAI-1 and adiponectin in 3T3-L1 differentiated adipocytes", Cytokine, 60, pp.150~156 (2012)
28. Aiello RJ, "Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice", Arterioscler Thromb Vasc Biol, 19, pp.1518~1525 (1999)
29. Ridker PM, "C-reactive protein, inflammation, and coronary risk", Cardiol Clin, 21, pp.315~325 (2003)
30. Ridker PM, "Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein", N Engl J Med, 359, pp.2195~2207 (2008)
31. Hubacek JA, "Possible gene-gender interaction between the SLCO1B1 polymorphism and statin treatment efficacy", Neuro Endocrinol Lett, 33(Suppl 2), pp.22~25 (2012)
32. Ivanov D, "Expression of cell adhesion molecule T-cadherin in the human vasculature", Histochem Cell Biol, 115, pp.231~242 (2001)
33. Ouchi N, "Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway", Circulation, 102, pp.1296~1301 (2000)

관련 논문AI추천